Are you Dr. Esrig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2400 Hartman Ln
Springfield, OR 97477Phone+1 541-334-3350Fax+1 541-284-5198
Summary
- Dr. David Esrig, MD is a board certified urologist in Springfield, Oregon. He is currently licensed to practice medicine in Oregon, Connecticut, and California. He is affiliated with PeaceHealth Sacred Heart Medical Center at RiverBend and McKenzie-Willamette Medical Center.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology, 1988 - 1992- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1986 - 1988
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - 2025
OR State Medical License 1998 - 2025
CT State Medical License 1994 - 1998- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 396 citationsp53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.David Esrig, Charles Spruck, Peter W. Nichols, Benjaporn Chaiwun, Kenneth Steven
The American Journal of Pathology. 1993-11-01 - 457 citationsTwo molecular pathways to transitional cell carcinoma of the bladder.Charles Spruck, Petra F. Ohneseit, Mirella Gonzalez-Zulueta, David Esrig, Noriomi Miyao
Cancer Research. 1994-02-01 - 157 citationsPhase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 StatusWalter M. Stadler, Seth P. Lerner, Susan Groshen, John P. Stein, Shan Rong Shi
Journal of Clinical Oncology. 2011-09-01
Grant Support
- Center OperationsNational Center For Research Resources2010–2011
- MVAC In Bladder Cancer Based On P53 StatusNational Cancer Institute1997
Professional Memberships
- Member
